Drug safety notice: Change of product – Enoxaparin injections

September 28, 2021

Due to a manufacturing problem with the supply of Clexane (enoxaparin) injections, the pharmacy department have sourced Inhixa, an alternative brand of enoxaparin, which has been approved for use within the Trust by the Formulary and Therapeutics Group.

Please see Enoxaparin information sheet for safety considerations and further details.

For more information please contact the pharmacy department on ext. 5263/3783.